U.S. moves to fill gap in treatments for COVID, as Delta variant creates worrying spike in new cases in the U.K.
June 18, 2021 at 10:14 AM EDT
The U.S. is planning to invest $3.2 billion to develop antivirals to treat COVID-19 and other viruses that have the potential to become pandemics, moving to fill the gap in treatments for such serious illnesses as Ebola, dengue, West Nile and Middle East respiratory syndrome.
